Clinical Trials

Women Experiencing Low Sex Drive (Hypoactive Sexual Desire Dysfunction)

enrollingNowWe're reaching out to let you know about the Reconnect Study, a research study we're conducting in our office for women with decreased sexual desire. This is a common condition, and if it's something you experience, we hope you'll consider taking part. The Reconnect Study is evaluating a "take as needed" investigational medication taken just before sexual activity.

Although many treatments for decreased sexual desire have been evaluated through clinical research, none have been approved for this condition. Participation in this study could lead to a new treatment and increased understanding about Hypoactive Sexual Desire Disorder.

The core study will last for approximately 32 weeks, and will require at least nine visits to the research site, and at least eight telephone conversations with the study staff between visits. If you complete the core study and want to continue and are eligible, you participate in the extension phase of the study. The extension phase will last for approximately 52 weeks, with at least eight visits to the research site, and at least eight telephone conversations with the study staff between visits.

To qualify, you must be:

You may qualify for this study if you:

  • Have experienced a decrease in your sexual desire over time
  • Feel distressed about this decreased sexual desire
  • Have been in a committed relationship for at least six months
  • Have not yet gone through menopause
  • Are not currently taking antidepressants or mood stabilizers
  • Are not currently experiencing depression or other psychological conditions.
  • Have not had a hysterectomy with bilateral oophorectomy

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

Hot Flashes (Women)

enrollingNow

Hot flashes are a natural part of life, but wouldn't it be refreshing if there were a way to control them and keep your cool through it all?

Women have hot flashes because of a decreased level of the hormone estrogen which occurs with menopause. The REPLENISH Study is a clinical research study evaluating an investigational medication for menopausal symptoms, like hot flashes and sweating.

The investigational medication being evaluated is a bio-identical hormone that may increase your hormone levels and prevent hot flashes so you can feel like yourself again. A bio-identical hormone is the same hormone that is already in your body.

To qualify, you must be:

  • Female between the ages of 40 and 65
  • Have not had a hysterectomy
  • Suffer from several hot flashes a day

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

Obesity with Cardiac Risk

enrollingNow

Have you had a heart attack or stroke?

Are you over age 45 and overweight?

If so, you may qualify for a clinical research study evaluating an investigational medication to see if it reduces the chances of developing health problems related to obesity such as another heart attack or stroke

This clinical trial is evaluating an investigational medication previously approved by the FDA for weight loss, versus placebo, to see if it will reduce an individual’s chance of developing health problems such as heart attack or stroke.

You may qualify if:

  • Are age 45 or older
  • Have cardiovascular risk, such as a heart attack or stroke
  • Are overweight

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

Overactive Bladder

enrollingNow

If you experience a frequent and sudden urge to urinate, followed by leakage or bladder control problems, you may be eligible to participate.

The Synergy study is a research study evaluating an investigational combination of two drugs prescribed for overactive bladder (OAB) to see if, when taken together, they maybe provide more relief than when taken on their own.

Who is eligible?

  • Men and women 18 years of age and older, who
  • Have symptoms of OAB that include uncontrolled leakage of urine
  • Have had symptoms for at least three months

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

Constipation due to Prescription Pain Meds

enrollingNow

Constipation can be a distressing side effect of some medications used to treat chronic pain and can have a negative effect on quality of life.

Over 6 million people (about 2% of the US population) use medications called opioids regularly to control chronic pain from conditions such as arthritis, osteoarthritis, back pain, neuropathy, migraines, fibromyalgia and others. The doctors at Sunstone Medical Research are now enrolling participants in an Opiate-Induced Constipation study now!

You may qualify to participate if you are:

  • Between 18-80 years old
  • Taking a stable daily dose of prescription pain medication
  • Experiencing constipation due to your pain medication

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

This study is up to 14 months in length with 7 visits to site and 9 telephone calls.

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

Fibromyalgia

enrollingNow

The symptoms of fibromyalgia can be debilitating. The pain, stiffness and fatigue can greatly impact the quality of your life.

You may qualify for this study if:

  • You are at least 18 years of age
  • You have been diagnosed with fibromyalgia, or are experiencing widespread persistent pain

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

This study is up to 12 weeks in length, with up to 8 visits to the study site.

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

COPD (Chronic Obstructive Pulmonary Disease)

enrollingNow

Breathing problems caused by smoking?

If you are a current, or former smoker, and struggle with chronic cough or shortness of breath, you may have a condition called COPD (also known as Chronic Bronchitis or Emphysema), and you have options.

Right now doctors at Sunstone Medical Research are conducting several clinical research studies for COPD.

You may be able to participate if you are:

  • A current or former smoker
  • 40 years of age or older
  • Have clinical history of COPD or experiencing shortness of breath

Eligible study participants:

  • May be reimbursed for time and travel
  • Will receive all study-related medical care at no cost
  • Will be seen by a study doctor
  • Will receive investigational study medication or placebo at no cost
  • Are not required to have insurance to participate

If you are interested in participating or have any questions, please call 541-973-2080 or email us.

Upcoming Trials

These studies are not yet enrolling, but if you would like more information click on Contact Us and join our email or mailing list for future trials.  To subscribe to our mailing list click on the Join Our Study Mailing List link on right side of this page.

  • Additional COPD studies
  • Painful Diabetic Neuropathy

footer